VAXABOV B.M. HYPERLIPIDEMIA-SPECIFIC BIOMARKERS WOULD IMPROVE CLINICAL DIAGNOSIS AND THERAPEUTIC TREATMENT AT EARLY DISEASE STAGES. Journal of Applied Science and Social Science, [S. l.], v. 15, n. 12, p. 627–630, 2025. Disponível em: https://www.internationaljournal.co.in/index.php/jasass/article/view/2669. Acesso em: 25 may. 2026.